Pharmacological and Mechanical Support Approaches in the Management of Acute Heart Failure in the Regional Network Model for the Management of Cardiogenic Shock

Launched by IRCCS AZIENDA OSPEDALIERO-UNIVERSITARIA DI BOLOGNA · Feb 13, 2025

Keywords

ClinConnect Summary

This clinical trial is studying a serious condition called cardiogenic shock, which occurs when the heart suddenly can't pump enough blood to meet the body's needs. The researchers aim to learn more about how often this condition happens, the reasons behind it, and how it affects patients of different ages and genders in the Emilia Romagna region. They will look at various factors, such as how long patients stay in the hospital, their chances of recovery, and the types of treatments they receive.

To participate in this study, individuals must be adults aged 18 or older who are admitted to a cardiac intensive care unit (CICU) with suspected cardiogenic shock. Participants will receive standard medical care based on their doctor’s judgement, as this study is observational and does not involve any new treatments being tested. It’s important to note that patients who have had recent heart surgery or significant injuries are not eligible for this trial. Overall, this study aims to provide valuable information that can help improve the understanding and management of cardiogenic shock in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adult patients (≥18 years old) admitted to a participating CICU with suspected CS of stage from C to E according to SCAI (Society of cardiovascular intervention)classification of cardiogenic shock.
• • Signed informed consent.
• Exclusion Criteria:
• • CS following cardiac surgery (post-cardiotomy), ● Significant polytrauma or neurological injury.